XML 30 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
-Based Compensation
 
In March 2006, the Company's Board of Directors approved the Steven Madden, Ltd. 2006 Stock Incentive Plan, as amended (the “Plan”), under which nonqualified stock options, stock appreciation rights, performance shares, restricted stock, other stock-based awards, and performance-based cash awards may be granted to employees, consultants and non-employee directors. The following table summarizes the number of shares of common stock authorized for use under the Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the Plan and the number of shares of common stock available for the grant of stock-based awards under the Plan: 

Common stock authorized
23,466,000

Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled
(21,528,000
)
Common stock available for grant of stock-based awards as of March 31, 2017
1,938,000



Total equity-based compensation for the three months ended March 31, 2017 and 2016 is as follows:

 
Three Months Ended March 31,
 
2017
 
2016
Restricted stock
$
4,214

 
$
4,143

Stock options
962

 
784

Total
$
5,176

 
$
4,927



Equity-based compensation is included in operating expenses on the Company’s Condensed Consolidated Statements of Income.






Note J – Equity-Based Compensation (continued)

Stock Options
 
Cash proceeds and intrinsic values related to total stock options exercised during the three months ended March 31, 2017 and 2016 are as follows:

 
Three Months Ended March 31,
 
2017
 
2016
Proceeds from stock options exercised
$
1,812

 
$
3,678

Intrinsic value of stock options exercised
$
1,011

 
$
11,030



During the three months ended March 31, 2017, options to purchase approximately 231,837 shares of common stock with a weighted average exercise price of $32.65 vested. During the three months ended March 31, 2016, options to purchase approximately 214,328 shares of common stock with a weighted average exercise price of $31.63 vested. As of March 31, 2017, there were unvested options relating to 1,264,540 shares of common stock outstanding with a total of $10,371 of unrecognized compensation cost and an average vesting period of 3.83 years.

The Company uses the Black-Scholes option-pricing model to estimate the fair value of options granted, which requires several assumptions. The expected term of the options represents the estimated period of time until exercise and is based on the historical experience of similar awards. Expected volatility is based on the historical volatility of the Company’s common stock. The risk
free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The Company historically has not paid regular cash dividends and thus the expected dividend rate is assumed to be zero. The following weighted average assumptions were used for stock options granted during the three months ended March 31, 2017 and 2016:

 
 
2017
 
2016
Volatility
 
23.2% to 26.4%
 
22.2% to 26.2%
Risk free interest rate
 
1.48% to 1.99%
 
1.20% to 1.73%
Expected life in years
 
3.4 to 5.0
 
3.8 to 5.0
Dividend yield
 
0.00%
 
0.00%
Weighted average fair value
 
$8.97
 
$7.26


Activity relating to stock options granted under the Company’s plans and outside the plans during the three months ended March 31, 2017 is as follows: 
 
 
Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term
 
Aggregate Intrinsic Value
Outstanding at January 1, 2017
 
1,499,000

 
$
29.72

 
 
 
 

Granted
 
899,000

 
37.06

 
 
 
 

Exercised
 
(74,000
)
 
24.29

 
 
 
 

Forfeited
 
(1,000
)
 
36.59

 
 
 
 

Outstanding at March 31, 2017
 
2,323,000

 
$
32.73

 
4.6 years
 
$
13,513

Exercisable at March 31, 2017
 
1,058,000

 
$
28.44

 
2.6 years
 
$
10,702



Note J – Equity-Based Compensation (continued)

Restricted Stock
 
The following table summarizes restricted stock activity during the three months ended March 31, 2017 and 2016:

 
 
2017
 
2016
 
 
Number of Shares
 
Weighted Average Fair Value at Grant Date
 
Number of Shares
 
Weighted Average Fair Value at Grant Date
Non-vested at January 1,
 
4,191,000

 
$
25.93

 
4,055,000

 
$
25.32

Granted
 
166,000

 
36.61

 
273,000

 
34.06

Vested
 
(125,000
)
 
33.15

 
(126,000
)
 
29.51

Forfeited
 
(3,000
)
 
34.77

 

 

Non-vested at March 31,
 
4,229,000

 
$
26.13

 
4,202,000

 
$
25.81



As of March 31, 2017, the Company had $72,689 of total unrecognized compensation cost related to restricted stock awards granted under the Plan. This cost is expected to be recognized over a weighted average of 6.00 years. The Company determines the fair value of its restricted stock awards based on the market price of its common stock on the date of grant.

On January 3, 2012, the Company and its Creative and Design Chief, Steven Madden, entered into an amendment of Mr. Madden’s existing employment agreement, pursuant to which, on February 8, 2012, Mr. Madden was granted 1,463,057 restricted shares of the Company’s common stock at the then market price of $27.34, which will vest in equal annual installments over a seven-year period commencing on December 31, 2017 and, thereafter, on each December 31 through December 31, 2023, subject to Mr. Madden’s continued employment on each such vesting date. On June 30, 2012, Mr. Madden exercised his right under his employment agreement to receive an additional restricted stock award, and, on July 3, 2012, he was granted 1,893,342 restricted shares of the Company's common stock at the then market price of $21.13, which will vest in the same manner as the aforementioned grant. On August 8, 2016, pursuant to the employment agreement, Mr. Madden was granted an option to purchase 150,000 shares
of the Company's common stock at an exercise price of $34.42 per share, which option is exercisable in equal quarterly installments commencing on November 8, 2016.